Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have been diagnosed with a blood cancer or malignant blood disease, confirmed through laboratory testing of tissue or cell samples
- People who have not previously had an allogeneic stem cell transplant (a transplant using cells from a donor)
- People with a general health and activity level rated between 0 and 2 on a standard medical scale (meaning able to carry out daily activities with at most moderate limitations)
- People whose kidney function, liver function, heart function, and blood oxygen levels fall within the specific acceptable ranges required by the trial (confirm with trial site for exact values)
- People whose doctors expect them to survive for longer than 12 weeks
- People who are willing to follow all study requirements and sign a consent form
Who may not be able to join:
- People who have received certain immune-suppressing treatments known as ATG, ALG, or ATLG within the past six months
- People who have a known allergy to any ingredient in the ATG or ATLG medications used in the trial
- People who have an active bacterial, viral, parasitic, or mycobacterial infection that is not well-controlled with treatment, and which would prevent a stem cell transplant from going ahead
- People who are pregnant or breastfeeding, or people who are capable of becoming pregnant but are unwilling or unable to use effective contraception during the trial
- People who have participated in another clinical trial involving an experimental drug or device within the 30 days before their first trial visit (those in observational studies only may still be considered)
- People where the treating doctor judges that any other condition or circumstance could interfere with the trial or its results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-13671375500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of viral infections after hematopoietic stem cell transplantation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.